Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Rhea-AI Summary

Aethlon Medical (Nasdaq: AEMD), a company developing products for cancer and infectious disease treatment, announced its participation in the 2024 Maxim Healthcare Virtual Summit. James Frakes, CEO and CFO, will engage in a fireside chat on October 15, 2024, at 4:30 pm ET.

The event, hosted by Anthony Vendetti, executive managing director and head of research at Maxim Group, offers an opportunity for investors to gain insights into Aethlon Medical's developments and strategies. Interested parties can access the company presentation by registering for the conference through the provided link.

SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that James Frakes, Chief Executive Officer and Chief Financial Officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit, hosted by Anthony Vendetti, executive managing director and head of research at Maxim Group, on Tuesday, October 15, 2024 at 4:30 pm ET.

To listen to the company presentation, sign up for the conference using this link.

About Aethlon and the Hemopurifier^®
Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful exosomes from biological fluids, utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Additional information can be found at www.AethlonMedical.com.

Company Contact:
Jim Frakes
Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com

View original content:https://www.prnewswire.com/news-releases/aethlon-medical-to-participate-in-the-2024-maxim-healthcare-virtual-summit-302269892.html

SOURCE Aethlon Medical, Inc.

FAQ

When is Aethlon Medical (AEMD) participating in the 2024 Maxim Healthcare Virtual Summit?

Aethlon Medical (AEMD) is participating in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 at 4:30 pm ET.

Who will represent Aethlon Medical (AEMD) at the 2024 Maxim Healthcare Virtual Summit?

James Frakes, Chief Executive Officer and Chief Financial Officer of Aethlon Medical (AEMD), will represent the company at the 2024 Maxim Healthcare Virtual Summit.

What type of presentation will Aethlon Medical (AEMD) give at the 2024 Maxim Healthcare Virtual Summit?

Aethlon Medical (AEMD) will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit.

Who is hosting the 2024 Maxim Healthcare Virtual Summit where Aethlon Medical (AEMD) is participating?

The 2024 Maxim Healthcare Virtual Summit is hosted by Anthony Vendetti, executive managing director and head of research at Maxim Group.

How can investors listen to Aethlon Medical's (AEMD) presentation at the 2024 Maxim Healthcare Virtual Summit?

Investors can listen to Aethlon Medical's (AEMD) presentation by signing up for the conference using the link provided in the press release.